BioLineRx Ltd. (NASDAQ:BLRX) should head towards $9.25 per share according to 2 Analysts in consensus. However, if the road gets shaky, the stock may fall short to $8 per share. The higher price estimate target is at $11 according to the Analysts.
Company has received rating and price target from many analysts . 2 analysts have suggested buy for the company.
Market Data 
Markets 
AI
